Real World Evidence to Assess the Value of a Digital Care Coordination and Monitoring Program for Supporting Caregivers of Adults Discharged From the Emergency Department. (RW-HOMECARE)

January 9, 2026 updated by: Fondation Hôpital Saint-Joseph

The RW-HOMECARE study is a prospective, longitudinal, real-world pilot trial designed to assess the impact of proposing the Monka digital solution to non-professional caregivers of patients discharged from emergency or short-stay units. The primary objective is to measure changes in caregiver burden using the ZBI-12 scale at baseline, 30 days, and 90 days. Secondary objectives include evaluating caregivers' physical and mental quality of life (SF-12), patient frailty (Clinical Frailty Scale), and the incidence of adverse events such as emergency visits, unplanned hospitalizations, falls, institutionalization, and death within 90 days. The study also examines the usability, acceptability, and satisfaction with Monka digital solution through standardized questionnaires, the correlation between algorithm-generated vulnerability scores and established measures, and reasons for non-adoption.

Eligible dyads (patient and caregiver) are recruited at discharge from emergency or short-stay units. After informed consent, caregivers receive free access to Monka digital solution for 3 months, along with a user guide. Follow-up assessments are conducted by phone at Day 30 and Day 90 (±14 days). All interventions by the coordinating nurse are tracked and analyzed quantitatively and qualitatively.

Study Overview

Study Type

Interventional

Enrollment (Estimated)

100

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Camilla GERLIER, Doctor
  • Phone Number: 01·44·12·80·23
  • Email: cgerlier@ghpsj.fr

Study Contact Backup

  • Name: Célia MAMMA
  • Phone Number: 01·44·12·32·54
  • Email: cmamma@ghpsj.fr

Study Locations

      • Paris, France, 75014
        • Recruiting
        • Hopital Paris Saint-Joseph
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

FOR THE PATIENT

  • Person aged 18 or over, treated in the Emergency Department or Emergency Beds
  • Affiliated with Social Security
  • Having an adult non-professional relative helping them with one or more activities of daily living
  • Having a medical decision to return home within the next 72 hours
  • Who has given their free, informed, and express consent FOR THE CAREGIVER
  • Individuals aged 18 or older
  • Who are non-professional caregivers as defined in Article L. 113-1-3 of the Social Action and Families Code, living with or separately from the person being cared for (20)
  • Providing assistance to the patient with one or more activities of daily living, i.e., shopping, medical appointments, coordination of care, administrative tasks, and moral support
  • Access to a cell phone, computer, or tablet with an internet connection
  • Having given their free, informed, and express consent

Exclusion Criteria:

FOR THE PATIENT

  • Non-French speakers
  • People living in a medical institution or scheduled for institutionalization within the next 3 months
  • People receiving home hospitalization (HAD) or palliative care at home
  • People under legal protection, deprived of their liberty, or under legal guardianship (tutelage or curatelle) FOR THE CAREGIVER
  • Non-French speakers
  • People with cognitive or psychiatric disorders that prevent them from understanding and using the MONKA solution
  • People under legal protection, deprived of their liberty, or under legal guardianship (tutelage or curatelle)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Patient and caregiver dyad experiencing the MyMonka solution in real-life conditions
Testing of the MyMonka solution; Response to questionnaires during the follow-up period on quality of life and burden measurement

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Change in the score on the 12-item Zarit Burden Interview questionnaire (ZBI-12, Appendix 1), measured on days 0, 30, and 90, among family caregivers participating in the study.
Time Frame: Days 0, 30 and 90
Days 0, 30 and 90

Secondary Outcome Measures

Outcome Measure
Time Frame
Change in the physical and mental quality of life of caregivers, expressed as the difference between SF-12 questionnaire scores at baseline, on day 30, and on day 90.
Time Frame: Days 30 and 90
Days 30 and 90
Change in patient frailty expressed as the difference between the Clinical Frailty Scale score obtained at inclusion and on day 90.
Time Frame: Days 0 and 90
Days 0 and 90
Percentage of people affected by the following adverse events within three months of returning home: new emergency room visits, unscheduled hospitalizations and their duration, falls, home hospitalizations, institutionalization, and death.
Time Frame: Days 90
Days 90
Evaluation of the use, acceptability, usability, and impact of the Monka digital solution for caregivers through intervention tracking, algorithm-based vulnerability assessment, and standardized questionnaires over a 90-day period.
Time Frame: Days 0 and 90
Days 0 and 90

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 12, 2025

Primary Completion (Estimated)

March 12, 2027

Study Completion (Estimated)

March 12, 2027

Study Registration Dates

First Submitted

December 11, 2025

First Submitted That Met QC Criteria

January 9, 2026

First Posted (Estimated)

January 16, 2026

Study Record Updates

Last Update Posted (Estimated)

January 16, 2026

Last Update Submitted That Met QC Criteria

January 9, 2026

Last Verified

January 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • 782_RW-HOMECARE
  • ID RCB : 2025-A02182-47 (Other Identifier: ANSM)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Frailty Syndrome

Clinical Trials on Caregivers supporting vulnerable patients and using the MyMonka solution.

Subscribe